There’s a new kid on the block for treating leukemia: Chimeric antigen receptor T therapy, or CAR-T.
With CAR-T, immune cells are extracted from a patient, genetically altered to better battle a particular cancer, and inserted back into the body to boost the body’s own fighting power. These modified cells are often referred to as “living drugs.”
The FDA recently approved CAR-T therapies to treat children and young adults with a form of acute lymphoblastic leukemia as well as adult patients with relapsed non-Hodgkin lymphoma. This therapy may ultimately be used for additional diseases, including leukemia, myeloma, and brain tumors.
Certain blood cancers originate in bone marrow, where blood cells are altered. The cancer then moves to the blood, where it spreads throughout the body. They cannot be prevented or screened for, so the health care community has focused on finding cures. Research companies continue to refine this CAR-T therapy.
For more information on innovative therapies, visit http://www.goboldly.com.